DEMPE attribution

Example 7 — Conduct contradicts the contract — recall risk

Annex I · Example 7 · ¶16–19 · Primero · pharma

OECD Guidelines 2022
At a glance
Primero contracts Company S as a limited-risk distributor for Product X and reserves all product-liability and recall risk. Three years in, the product is recalled — and Company S, not Primero, ends up bearing the recall costs. Which side is the inconsistency on?
Primero
Parent · owns Product X IP · contracted to bear recall risk
Product X · agreed limited-risk distribution
Company S
Limited-risk distributor in Europe & Middle East
  1. Primero develops and patents Product X and registers its IP worldwide.
  2. Primero appoints Company S as a limited-risk distributor for Europe and the Middle East.
  3. Contract: Primero retains product-recall and product-liability risk; Company S earns a limited-risk return.
  4. Three years in, serious side effects emerge and Primero recalls the product.
  5. Company S incurs substantial recall costs; Primero does not reimburse them or product-liability claims.

The contract says Primero carries recall risk. In practice, Company S ate the recall costs — while Primero still kept the upside on the product.

How should this be adjusted?

OECD analysis · Reallocate recall costs
There is an inconsistency between Primero's asserted entitlement to intangible returns and its failure to bear the associated risk costs. If the true relationship is a limited-risk distribution, the appropriate adjustment is to allocate the recall and product-liability costs from Company S to Primero. Less plausibly, if conduct shows Company S in fact controls the relevant risks, its distribution margins for all years could be increased.
Key takeaway
Asserting risk in the contract and dodging it in practice is not arm's-length. Conduct is the test: if the principal claims the residual, it must absorb the downside.

Related: Chapter I · Section D.1 · Section B.2.4 (risk control)

Test yourself on this example.Open it in the interactive walkthrough →